Skip to main content
. 2013 Oct 8;305(11):E1367–E1374. doi: 10.1152/ajpendo.00413.2013

Fig. 4.

Fig. 4.

A: intra-VTA injection of Ex-4 (0.05 μg; vehicle, 100 nl of aCSF) increased VTA tyrosine hydrolase (TH; normalized to β-actin) 15 min after drug administration. B: representative immunoblots for TH and β-actin are shown. *P ≤ 0.05 compared with aCSF. Data are shown as means ± SE.